Antibody Drug Conjugates (ADCs) are transforming the landscape of targeted therapeutics—but with innovation comes complexity. In this expert-led webinar, Chaise DeVries, Dan Cremer, and Paul Coiteux from ATS Life Sciences Group will explore the emerging trends, key challenges, and proven approaches shaping the future of ADC manufacturing. Discover how ATS Life Sciences Group is redefining precision and compliance through an integrated strategy that meets the demands of high-potency handling, regulatory alignment, and efficient project execution.
Dan Cremer has been a valued member of the ATS Automation team for over 20 years, contributing his expertise across both the North American and European markets. Over the course of his tenure, he has held key roles in Project Management, Operations, and Sales Leadership—bringing a wealth of experience and a deep understanding of automation technologies to every facet of the business.
Andrea Zanotto is the Product Manager for Aseptic Fill Finish at Comecer, bringing over a decade of experience in aseptic processing, containment technologies, and pharmaceutical equipment design. His career encompasses roles in mechanical design engineering, project management, and technical sales support, with a focus on aseptic filling machines and transfer technologies. Andrea has led complex projects across global markets, and is recognized for his expertise within the pharmaceutical manufacturing sector.
Paul Coiteux has been a valued member of the Scientific Products team for over 24 years and currently holds global responsibility for the SME team. During his tenure, he has served in several roles spanning Project Management, Outside Sales, and Sales Leadership—with a particular focus on research and production lyophilization, especially scale-up technologies.
Speakers
Dan Cremer
Sales Manager, ATS Life Science Systems
Andrea Zanotto
Product Manager (Aseptic Fill-Finish), Comecer
Paul Coiteux
Senior Director, Subject Matter Expert Team, SP Industries Inc.